These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25005758)
1. A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway. Hsu JL; Liu SP; Lee CC; Hsu LC; Ho YF; Huang HS; Guh JH Naunyn Schmiedebergs Arch Pharmacol; 2014 Oct; 387(10):979-90. PubMed ID: 25005758 [TBL] [Abstract][Full Text] [Related]
2. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
3. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation. Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757 [TBL] [Abstract][Full Text] [Related]
4. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling. Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592 [TBL] [Abstract][Full Text] [Related]
5. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways. Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake. Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475 [TBL] [Abstract][Full Text] [Related]
7. The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis. Sheng YH; Leu WJ; Chen CN; Hsu JL; Liu YT; Hsu LC; Hou DR; Guh JH Molecules; 2020 Jun; 25(12):. PubMed ID: 32630532 [TBL] [Abstract][Full Text] [Related]
8. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor. Liu JL; Mao Z; Gallick GE; Yung WK Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367 [TBL] [Abstract][Full Text] [Related]
9. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783 [TBL] [Abstract][Full Text] [Related]
10. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells. Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462 [TBL] [Abstract][Full Text] [Related]
11. A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest. Majd S; Power JHT; Chataway TK; Grantham HJM BMC Cell Biol; 2018 Jun; 19(1):7. PubMed ID: 29921218 [TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells. Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047 [TBL] [Abstract][Full Text] [Related]
13. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Li W; Hua B; Saud SM; Lin H; Hou W; Matter MS; Jia L; Colburn NH; Young MR Mol Carcinog; 2015 Oct; 54(10):1096-109. PubMed ID: 24838344 [TBL] [Abstract][Full Text] [Related]
14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase. Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819 [TBL] [Abstract][Full Text] [Related]
15. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway. Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894 [TBL] [Abstract][Full Text] [Related]
16. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis. Hwang YJ; Park JH; Cho DH J Korean Med Sci; 2020 Sep; 35(35):e289. PubMed ID: 32893519 [TBL] [Abstract][Full Text] [Related]
17. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway. Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673 [TBL] [Abstract][Full Text] [Related]
18. Acetylshikonin induces autophagy-dependent apoptosis through the key LKB1-AMPK and PI3K/Akt-regulated mTOR signalling pathways in HL-60 cells. Wu MD; Zhang YY; Yi SY; Sun BB; Lan J; Jiang HM; Hao GP J Cell Mol Med; 2022 Mar; 26(5):1606-1620. PubMed ID: 35106915 [TBL] [Abstract][Full Text] [Related]
19. TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway. Xu X; Gao H; Qin J; He L; Liu W Int J Clin Exp Pathol; 2015; 8(9):10824-31. PubMed ID: 26617795 [TBL] [Abstract][Full Text] [Related]
20. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties. MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]